High prevalence of human papillomavirus DNA detected in cervical swabs from women in Southern Selangor, Malaysia

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 6, 2010, Pages 1645-1651

  Chong, P P ^a,b   Asyikin, N ^a   Rusinahayati, M ^a   Halimatun, S ^a   Rozita, R ^a   Ng, C K ^c   Hamilton, W H Wan ^d   Tan, B C ^e   Noraihan, N ^f   Rohani, A ^a   Faezah, H ^a   Latiffah, L ^a   Maha, A ^a   Sabariah, A R ^a  

^a Faculty of Health Sciences   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c Hospital Kajang   (Malaysia)

^d Hospital Serdang   (Malaysia)

^e Britannia Women and Children Specialist Centre   (Malaysia)

^f PUTRAJAYA HOSPITAL   (Malaysia)

Author keywords

Cervical cancer; Human papillomavirus (HPV); Malaysian women; Nested PCR

Indexed keywords

EID: 79956142902     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bao YP, Li N, Smith JS, Qiao YL, et al (2008). Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer, 18, 71-7.
2. Bardin A, Vaccarella S, Clifford GM, et al (2008). Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer, 44, 557-64.
3. Bell MC, Grimminger DS, Patrick S, et al (2007). There is high prevalence of human papillomavirus infection in american Indian women of northern plains. Gynecol Oncol, 107, 236-41.
4. Berumen J, Ordonez RM, Lazcano E (2001). Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Nat Cancer Inst, 93, 1325-30.
5. Castellsague X, Diaz M, de Sanjose S, et al (2006). Worldwide human papillomavirus: etiology of cervical adenocarcinoma and its cofactors; implications for screening and prevention. J Natl Cancer Inst, 98, 303-15.
6. Chakrabarti O, Veeraraghavalu K, Tergaonkar V, et al (2004). Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol, 78, 5934-45.
7. Clifford GM, Gallus S, Herrero R, et al (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the international agency for research on cancer HPV prevalence surveys: a pooled analysis. Lancet, 366, 991-8.
8. Cochran WG (1977). Sampling techniques, 3rd edition, john wiley and sons, New York pp1-30
9. De Boer MA, Peters LA, Aziz MF, et al (2005). Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer, 114, 422-5.
10. Ferlay J, Bray F, Pisani P, et al (2004). GLOBOCAN, 2002. Cancer incidence, mortality, and prevalence worldwide version 2.0 IARC cancerbase, vol. 5, IARC Press, Lyon
11. Figueroa JP, Ward E, Luthi TE, et al (1995). Prevalence of human papillomavirus among STD clinic attenders in jamaica: association of younger age and increased sexual activity. Sex Transm Dis, 22, 114-8.
12. Gravitt PE, Jamshidi R (2005). Diagnosis and management of oncogenic cervical human papillomavirus infection. Inf Dis Clin N Am, 19, 439-58.
13. Jacobs MV, Snidjers PJ, van den Brule AJ, et al (1997). A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol, 35, 791-5.
14. Kahn JA (2005). Vaccination as a prevention strategy for human papillomavirus-related diseases. J Adolesc Hlth, 37, S10-6.
15. Lim GCC, Halimah Y (2004). Cancer incidence in Malaysia 2003, in second report of the national cancer registry. National Cancer Registry, Kuala Lumpur.
16. Lizano M, De la Cruz-Hernandez E, Carrillo-Garcia A, et al (2005). Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a mexican population. Gynecol Oncol, 102, 230-5.
17. Muñoz N, Bosch FX, de Sanjosé S, et al (2003). International agency for research on cancer multicenter cervical cancer study group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
18. Muñoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus type associated with cervical cancer. N Engl J Med, 348, 518-27.
19. Moscicki AB, Shiboski S, Broering J, et al (1998). The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr, 132, 277-84.
20. Pagliusi SR, Aguado T (2004). Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine, 23, 569-78.
21. Sapy T, Poka R, Szarka K, et al (2008). Age-specific prevalence of high-risk human papillomavirus infection in a hungarian female population with positive cytology. Eur J Obstet Gynecol Reprod Biol, 138, 194-8.
22. Scheurer ME, Tortolero-Luna G, Adler-Storthz K (2005). Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer, 15, 727-46.
23. Schiffman MH, Bauer HM, Lorincz AT, et al (1991). Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol, 29, 573-7.
24. Sowjanya AP, Jain M, Poli UR, et al (2005). Prevalence and distribution of high risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis, 5, 116.
25. Stoppler MC, Ching K, Stoppler H, et al (1996). Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol, 70, 6987-93.
26. Wong LP, Sam IC (2007). Current issues facing the introduction of human papillomavirus vaccine in Malaysia. Malaysian Family Physician, 2, 47-53.